Dent Paul
Department of Biochemistry and Molecular Biology; Massey Cancer Center; Virginia Commonwealth University; Richmond, VA USA.
Cancer Biol Ther. 2014 May;15(5):481-2. doi: 10.4161/cbt.28465. Epub 2014 Mar 11.
Downstream of growth factor receptors, signaling by the phosphoinositide 3 kinase (PI3K) pathway is known to play an important role in the growth and survival of many tumor types. The PI3K pathway simplistically comprises PI3K itself, followed by PDK-1, then AKT and finally glycogen synthase kinase 3 (GSK3). PI3K/AKT signaling promotes increased GSK3 phosphorylation, that is associated with reduced GSK3 activity. There are two isoforms of GSK3, GSK3α and GSK3β, which have a high degree of sequence homology. GSK3 plays a role not only in the regulation of glycogen synthase activity but in the expression of multiple other proteins that play a role in cancer biology, including cyclins and anti-apoptotic proteins.
在生长因子受体的下游,磷酸肌醇3激酶(PI3K)信号通路在多种肿瘤类型的生长和存活中发挥重要作用。PI3K信号通路简单地包括PI3K本身,接着是PDK-1,然后是AKT,最后是糖原合酶激酶3(GSK3)。PI3K/AKT信号传导促进GSK3磷酸化增加,这与GSK3活性降低有关。GSK3有两种亚型,GSK3α和GSK3β,它们具有高度的序列同源性。GSK3不仅在糖原合酶活性的调节中起作用,而且在多种其他在癌症生物学中起作用的蛋白质的表达中起作用,包括细胞周期蛋白和抗凋亡蛋白。